MEDICINES EVALUATION UNIT LIMITED
Significant control: Iqvia Ltd. (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Medicines Evaluation Unit Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Medicines Evaluation Unit Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MEDICINES EVALUATION UNIT LIMITED is an active private limited company (company number 03779957) incorporated on 28 May 1999, registered in Reading. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest medium accounts cover the period ending 31 March 2025, showing net assets of £38.30m and cash of £33.22m, with 160 employees on average. Turnover was £18.19m and profit for the year £5.34m. Net assets rose 13% on the prior period (£34.02m).
By net assets it sits in the top quarter of 77 comparable companies in Reading (median £6,810, upper quartile £93k).
Ownership and control
- Iqvia Ltd.
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- North West Lung Research Centre Charity
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 28 May 199927 yrs ago
- Next accounts due
- 31 December 2026in 65 days
- Confirmation statement due
- 11 June 2027in 227 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Medium
- Size band
- MediumCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £38.30m | £33.22m | £4.59m | — | £18.19m | £5.34m | 160 |
| 31 March 2024 | £34.02m | £19.50m | £6.74m | — | £18.17m | £7.36m | 149 |
| 31 March 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £38,296,895 at 31 March 2025
- Net assets up 10% or more on the prior period+12.6% vs prior period
- Cash at bank of £50,000 or moreCash £33,216,149
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 28 May 1999
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 227 days
- Next accounts duein 65 days
- Accounts period endNet assets £38.30m · medium accounts
- Accounts period endNet assets £34.02m · medium accounts
- Accounts period end
- Incorporated
Similar companies in Reading
- PROVEXIS NATURAL PRODUCTS LIMITEDReading · inc. Oct 1999
- APPLEDOWN CLINICAL RESEARCH LIMITEDBourne End · inc. Nov 1999
- ZEIN BIOTEC LIMITEDNewbury · inc. Sept 1998
- TCORE LIMITEDReading · inc. Mar 2000
- PROMISE.TV LIMITEDBerkshire · inc. Feb 1998
- BROADCOM EUROPE LIMITEDReading · inc. Oct 2000
All companies incorporated on 28 May 1999 · in May 1999.
Reminders for MEDICINES EVALUATION UNIT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.